BLND Form 4: Oxana Tkach Sells 101,429 Shares Under 10b5-1 Plan

Rhea-AI Filing Summary

Oxana Tkach, Principal Accounting Officer at Blend Labs, Inc. (BLND), reported an insider sale executed under a pre-established Rule 10b5-1 plan. On 09/05/2025 the Form 4 discloses the disposition of 101,429 shares of Class A common stock at a weighted average sale price of $4.0026 per share. Following the reported sales, the filing states the reporting person beneficially owned 52,780 shares as a direct holder. The Form 4 was signed by attorney-in-fact Winnie Ling on 09/09/2025. The filing notes the 10b5-1 plan was adopted on March 14, 2025, and the sale price range realized was $4.00 to $4.005 per share.

Insights

Financial Analyst

TL;DR: Routine insider sale under a 10b5-1 plan; transaction size and post-sale holdings disclosed, no new operational data.

The Form 4 reports a planned disposition of 101,429 Class A shares at a weighted average of $4.0026 per share, executed under a 10b5-1 plan adopted March 14, 2025. The reporting person retains 52,780 shares after the sale. From a financial-analyst perspective this is a disclosure of insider liquidity rather than operational or financial performance; it does not provide revenue or earnings information and is neutral for valuation absent additional context.

Corporate Governance Expert

TL;DR: The sale was conducted through an established 10b5-1 plan and properly reported, reflecting procedural compliance.

The filing documents compliance with Section 16 reporting requirements and notes the transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025. Signature by an attorney-in-fact is included. This indicates adherence to disclosure protocols; there is no indication of undisclosed related-party transactions or amendments in this Form 4.

Insider Trade Summary

Net Seller: 101,429 shares ($405,980)

Net Sell 1 txn

Insider Tkach Oxana

Role PRINCIPAL ACCOUNTING OFFICER

Sold 101,429 shs ($406K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	101,429	$4.0026	$406K

Holdings After Transaction: Class A Common Stock — 52,780 shares (Direct)

Footnotes (1)

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. This sale price represents the weighted average sale price of the shares sold ranging from $4.00 to $4.005 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tkach Oxana

(Last) (First) (Middle)

7250 REDWOOD BLVD., SUITE 300

(Street)

NOVATO CA 94945

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Blend Labs, Inc. [ BLND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRINCIPAL ACCOUNTING OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/05/2025		S(1)		101,429	D	$4.0026(2)	52,780	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

2. This sale price represents the weighted average sale price of the shares sold ranging from $4.00 to $4.005 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

	/s/ Winnie Ling, Attorney-in-fact	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.